OraVerse Injection (2018-04-20) Apr 20, 2018 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type III
Lot or serial number Companies Brand name Dosage form DIN, NPN, DIN-HIM Strength D01894D Recalling Firm N/A Marketing Authorization Holder SEPTODONT OraVerse Injection Powder for solution DIN 02421666 phentolamine mesylate Injection 0.4 mg/1.7 mL
Affected Products
OraVerse Injection
Out of specification for phentolamine mesylate assay in lot D01894D. Out of trend for degradation product impurity (phentolamide) in lots D01894D and D01894F.
Wholesalers in ON, QC, AB and BC